Seoul: South Korea is authorized for the use of an antivirus Pfizer post that targets Covid-19 as the first of its kind to be introduced in South Korea, the Narcotics Food and Security Ministry said on Monday.
South Korea restored a difficult sidewalk last week after facilitating them in November, after a series of new infection records every day and serious cases stretched medical services, although the vaccination rate was more than 92% for those aged 182%.
Oral Pfizer antivirus treatment, called paxlovid, “is expected to help prevent serious damage to press direction patients.
This drug will be used for adults or children aged 12 years or more than 40 kilograms with minor symptoms with high risk Coronavirus case is severe because of the causes such as the underlying disease.
Other oral coronavirus care called Molnupiravir, developed by Merck known as MSD outside the United States and Canada, applied to emergency use earlier this month, but the Ministry is still reviewing because of them Requires additional info about efficacy, Kim said.